Nick Smith | Vice President of Corporate Development & Investor Relations |
Norbert Riedel | Chief Executive Officer |
Ashish Khanna | Chief Financial Officer & Chief Business Officer |
Andy Kidd | President & Chief Operating Officer |
Kathryn King | Senior Vice President of Clinical Development |
Harald Murck | Vice President of Medical & Pharmacovigilance |
Ritu Baral | Cowen |
Rudy Li | SVB Leerink |
Chris Raymond | Piper Sandler |
Joon Lee | Truist Securities |
Gary Nachman | BMO Capital Markets |
Charles Duncan | Cantor Fitzgerald |
Laura Chico | Wedbush Securities |
Myles Minter | William Blair |
Jessica Fye | JPMorgan |
Good afternoon, and welcome to the Aptinyx Fourth Quarter and Year-End 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open up the call for your questions. Please be advised that the call is being recorded at the Company's request. At this time, I would like to turn the call over to Nick Smith, Vice President of Corporate Development and Investor Relations of Aptinyx.